Intracameral toxicity of bacterial components muramyl dipeptide and staurosporine: Ciliary cyst formation, epithelial cell apoptosis and necrosis

Cutaneous and Ocular Toxicology

Volumn 25, Issue 2, 2006, Pages 85-101

  Langford, Marlyn P ^a   Chen, Dequan ^a   Gosslee, Jeffrey ^a   Misra, Raghunath P ^a   Redens, Thomas B ^a   Texada, Donald E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Apoptosis; Bacteria; Ciliary cysts; Endophthalmitis; Muramyl dipeptide; Staurosporine

Indexed keywords

CASPASE 3; DYE; EYE PROTEIN; MURAMYL DIPEPTIDE; STAUROSPORINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; AQUEOUS HUMOR; ARTICLE; BACTERIAL CELL WALL; CELL CULTURE; CELL DEATH; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; CYST; CYTOTOXICITY; ENDOPHTHALMITIS; ENZYME ACTIVITY; ENZYME LOCALIZATION; HISTOLOGY; IMMUNOREACTIVITY; IRIDOCYCLITIS; NONHUMAN; RABBIT; SYMPTOMATOLOGY; UVEA;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ANIMALS; APOPTOSIS; BACTERIA; CASPASE 3; CASPASES; CILIARY BODY; CYSTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT ANTIBODY TECHNIQUE; NECROSIS; PLACEBOS; RABBITS; STAUROSPORINE; UVEITIS;

BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS;

EID: 33745058640     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520600695538     Document Type: Article

References (39)

1. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature 1980; 286(5773):611-613.
2. Chang YH, Pearson CM, Chedid L. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan. J Exp Med 1981; 153(4):1021-1026.
3. Karnovsky ML. Muramyl peptides in mammalian tissues and their effects at the cellular level. Fed Proc 1986; 68(11):19-25.
4. Zidek Z. Immune-related edemagenic activity of glutamines and glutamic acid, components of immuno-modulatory agents. Agents Actions 1994; 42(3-4):163-136.
5. Riveau G, Masek K, Parant M, Chedid L. Central pyrogenic activity of muramyl dipeptide. J Exp Med 1980; 152(4):869-877.
6. Biberstine KJ, Rosenthal RS. Peptidoglycan fragments decrease food intake and body weight gain in rats. Infect Immun 1994; 62(8):3276-3281.
7. Krueger JM, Pappenheimer JR, Karnovsky ML. Sleep-promoting effects of muramyl peptides. Proc Natl Acad Sci USA 1982; 79(19):6102-6106.
8. Waters RV, Terrel TG, Jones GH. Uveitis induction in rabbit by muramyl dipeptides. Infect Immun 1986; 51(3):816-825.
9. Nagao S, Tanaka A. Muramyl dipeptide-induced adjuvant arthritis. Infect Immun 1980; 28(2):624-626.
10. Burroughs M, Rodzdzinski E, Geelen S, Tuomanen E. A structure-activity relationship for induction of meningeal inflammation by muramylpeptides. J Clin Invest 1993; 92(1):297-302.
11. Dewhirst FE. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture. Infect Immun 1982; 35(1):133-137.
12. Kawabata Y, Yang TS, Yokochi TT, Matsushita M, Fujita T, Shibazaki M, Noikura T, Endo TY, Takada H. Complement system is involved in anaphylactoid reaction induced by lipopolysaccharides in muramyldipeptide-treated mice. Shock 2000; 14(5):572-577.
13. Kuroe K, Haga Y, Funakoshi O, Kanazawa K, Mizuki I, Yoshida Y. Pericholangitis in a rabbit colitis model induced by injection of muramyl dipeptide emulsified with a long-chain fatty acid. J Gastroenterol 1996; 31(3):347-352.
14. Nagao S, Tanaka A. Necrotic inflammatory reaction induced by muramyl dipeptide in guinea pigs sensitized by tubercle bacilli. J Exp Med 1985; 162(2):401-412.
15. Kotani S, Tsujimoto M, Koga T, Nagao S, Tanaka A, Kawata S. Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed Proc 1986; 45(11):2534-2540.
16. Silverman DH, Krueger JM, Karnovsky ML. Specific binding sites for muramyl peptides on murine macrophages. J Immunol 1986; 136(6):2195-2201.
17. Dziarski R, Tapping RI, Tobias PS. Binding of bacterial peptidoglycan to CD14. J Biol Chem 1998; 273(15):8680-8690.
18. Yoshimura A, Takada H, Kaneko T, Kato I, Golenbock D, Hara Y. Structural requirements of muramylpeptides for induction of toll-like receptor 2-mediated NF-kappaB activation in CHO cells. J Endotoxin Res 2000; 6(5):407-410.
19. Root-Bernstein RS, Westall FC. Serotonin binding sites. II. Muramyl dipeptide binds to serotonin binding sites on myelin basic protein, LHRH, and MSH-ACTH. Brain Res Bull 1990; 25(6):827-841.
20. Sevcik J, Masek K. The interaction of immunomodulatory muramyl dipeptide with peripheral 5-HT receptors: overview of the current state. Int J Immunopharmacol 1999; 21(3):227-232.
21. Langford MP, Chen D, Welbourne TC, Redens TB, Ganley JP. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine). Molec Cell Biochem 2002; 236(1-2):63-73.
22. 13 cells. J Biol Chem 2005; 280(23):22425-22436.
23. Langford MP, Chen D, Neff AG, Redens TB, Berg ME, Ganley JP, Dass P, Welbourne TC. Intracameral muramyl dipeptide-induced paracellular permeability associated with decreased glutamate transporter and γ- glutamyltranspeptidase activities. Exp Eye Res 1999; 68(5):591-600.
24. Langford MP, Orillac R, Chen D, Texada DE. Systemic and ocular antibody responses to inactivated acute hemorrhagic conjunctivitis (AHC) virus; enterovirus 70 (EV70). Ocular Immunol Inflamm 2003; 11(3):197-209.
25. Andersson M, Sjöstrand J, Peterson A, Honarvar KS, Karlsson J-O. Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells. Invest Ophthalmol Vis Sci 2000; 41:2623-2632.
26. Thuret G, Chiquet C, Herrag S, Dumollard J-M, Boudard D, Bednarz J, Campas L, Gain P. Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line. Brit J Ophthalmol 2003; 87:346-352.
27. Langford MP, Yin-Murphy M, Barber JC, Heard HK, Stanton GJ. Conjunctivitis in rabbits caused by enterovirus type 70 (EV70). Invest Ophthalmol Vis Sci 1986; 27:915-920.
28. Alnemri ES. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J Cell Biochem 1997; 64(1):33-42.
29. Charalampopoulos I, Tsatsanis C, Demitazaki E, Alexaki V-I, Castanas E, Margoioris AN, Gravanis A. Dehydroepiandrosterone and allopregnanolone protect symathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc Natl Acad Sci USA 2004; 101:8209-8214.
30. Hogan MJ, Zimmerman LE. Hypotony. In Ophthalmic Pathology, 2nd ed. Philadelphia, PA: WB Sanders Company, 1962:717-718.
31. Slusher MM. Pseudophakic choroidal detachment with cyclodialysis cyst. Ophthalmic Surg 1987; 18(3):191-194.
32. Gentile RC, Liebmann JM, Tello C, Stegman Z, Weissman SS, Ritch R. Ciliary body enlargement and cyst formation in uveitis. Br J Ophthalmol 1996; 80(10):895-899.
33. Freddo TF, Bartels SP, Barsotti MF, Kamm RD. The source of proteins in the aqueous humor of the normal rabbit. Invest Ophthalmol Vis Sci 1990; 31(1):125-137.
34. Vegge T, Neufeld AH, Sears ML. Morphology of the breakdown of the blood-aqueous barrier in the ciliary processes of the rabbit eye after prostaglandin E2. Invest Ophthalmol 1975; 14(1):33-36.
35. Cusato K, Zakevicius J, Ripps H. An experimental approach to the study of gap-junction-mediated cell death. Biol Bull 2003; 205(2):197-199.
36. Kufoy E, Fox K, Fox A, Parks C, Pakalnis V. Modulation of the blood-aqueous barrier by gram positive and gram negative bacterial cell wall components in rat and rabbit. Exp Eye Res 1990; 50(2): 189-195.
37. Johnson S, Michalak M, Opas M, Eggleton P. The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol 2001; 11(3):122-129.
38. Li T, Fox K, Fox A, Pakalnis V. Recurrent anterior uveitis by multiple systemic injections of muramyl dipeptide. Exp Eye Res 1993; 57(1):79-87.
39. Gamble CN, Aronson SB, Brescia FB. Experimental uveitis. I. The production of recurrent immunologic (Auer) uveitis and its relationship to increased uveal vascular permeability. Arch Ophthalmol 1970; 84(3):321-330.